A simple, rapid screening procedure for determining the relative amounts of pancreatic (P)-and salivary (S)-type amylase in serum is presented, involving incorporation of a selective inhibitor (from wheat-germ) into commercially available BMD Single-Vial Amylase and Beckman Enzymatic Amylase-DS procedures for manual and automated isoamylase measurements.
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A simple, rapid screening procedure for determining the relative amounts of pancreatic (P)-and salivary (S)-type amylase in serum is presented, involving incorporation of a selective inhibitor (from wheat-germ) into commercially available BMD Single-Vial Amylase and Beckman Enzymatic Amylase-DS procedures for manual and automated isoamylase measurements.
Optimal concentrations of inhibitor inhibit the S-type amylase fraction by 87-88%.
In contrast,the pancreatic fraction is inhibited by only 19% in either the manual or automated methods. The degree of inhibition is constant for amylase activities up to at least 520 U/L. Use of the ratio (P-amylase/total amylase activity) X 100 helps differentiate between hyperamylasemia causedby S-type or P-typeamylase. in preliminary studies, patients with pancreatitis showed a ratio >70%. 
Material and Methods

Apparatus.
For and adding 400 AL of amylase reagent. After a 5-mm preincubation, the reaction is initiated and readings are taken after a 5-mm lag time. Figure 1 react with the enzyme to form an enzyme-inhibitor complex, before the substrate is added. Adding the inhibitor directly to the substrate, followed by addition of the enzyme, leads to less inhibition, possibly because a substrate-inhibitor complex may form (9) .
Results and Discussion
Standard curve. A standard curve can be prepared by mixing various proportions of saliva and pancreatic extract, and determining the respective activity of each in the presence and absence of amylase inhibitor.
The mixture of P-and 5-type amylase is best represented by the ratio between P-isoenzyme activity and total activity (T) (=P + S) activity X 100. relationship when they used the "Phadebas" method (Pharmacia AB, Uppsala, Sweden) and the same inhibitor. This may have been the result of either a different affinity of inhibitor to substrate, or the longer reaction period, which would allow a greater degree of dissociation of the enzyme-inhibitor complex, as discussed above. Precision of the proposed method. The procedure without inhibitor, as determined on 20 patients' sera with normal and increased total amylase activity, measured in a single run, gave electrophoresis, reported 55% (SD 12%) of P-type amylase. These differences must be attributed to differences in methodology. The method of selected inhibition, as already pointed out by Berk et al. (12) 
Clinical utility.
Some initial data obtained with this method for serum from patients with hyperamylasemia are shown in Table 1 . In each of the five examples of pancreatitis listed, the percent of P-type isoamylase (73-96%) exceeded the normal range for this ratio, which is 27-70% (mean 48%). In the two examples of carcinoma of the lung, the (P/T) X 100 ratio was substantially lower (15 and 20%) than the reference interval. A serum specimen collected from a patient just after oral surgery showed a ratio of 29%.
The P-type amylase activity in the serum of 27 healthy individuals with a total amylase activity of 34-124 U/L (mean 63) and a (PIT) X 100 ratio of 27-70% (mean 48%) was found to be 16-45 U/L (mean 29) and for the S-type amylase U/L (mean 34).
The observed activities for P-and S-type amylase differ slightly from those observed by other authors. Gillard (10) , using quantitative polyacrylamide gel electrophoresis, found an average of 43% (SD 8%) of P-type amylase in sara of healthy persons, while Legaz and Kenny (11) , using cellulose acetate
